MilliporeSigma in Jaffrey is Growing

MilliporeSigma in Jaffrey is broadening its manufacturing footprint with a combined $47-million investment at its production facilities in Jaffrey and Danvers, Massachusetts. These sites supply critical products to customers developing lifesaving therapies, including COVID-19 vaccines, as well as provide products and services for biopharmaceutical manufacturing. These expansions will significantly increase capacity and output at these facilities in 2021 and 2022, respectively, and create nearly 700 new manufacturing positions.

“The global coronavirus pandemic has significantly increased demand for our single-use and virus filtration technologies, which we are supplying to more than 50 different companies working on COVID-19 vaccine candidates,” said Chris Ross, interim CEO, MilliporeSigma. “These investments will strengthen our global manufacturing footprint, allowing us to meet this unprecedented demand and help get lifesaving vaccines and therapies to more patients, faster.”

The Jaffrey expansion includes adding 25,000 square feet to the existing 260,000-square-foot facility. The addition will include new production lines and equipment for the company's manufacture of filtration devices and membrane products, specifically Durapore filters, Express filters, and the Viresolve product lines. These products are used to ensure the sterility of many lifesaving therapies and to remove viral contamination in various therapies. The Jaffrey investment is about $22 million and is expected to add nearly 275 jobs by 2022, once the expansion is completed.

In Danvers, the expansion will add 65,000 square feet to the assembly operations, adding to the existing 120,000-square-foot facility. This will help the company in the manufacturing of products across several portfolios, including MilliporeSigma’s Mobius single-use consumables. The total investment in Danvers is about $25 million and it will add about 400 jobs throughout 2021.

These expansions join MilliporeSigma’s investments announced in 2020 to further enhance capabilities and capacity in Buchs, Switzerland; Carlsbad, California; Madison, Wisconsin; and Darmstadt, Germany, broadening the company’s global manufacturing footprint.